Greenphire, a provider of payment technologies for clinical trials, has expanded into the European market with the opening of its London office.  The expansion is the result of increased adoption within the life sciences industry for global payment technology platforms for Patient and Investigator payments.   Sam Whitaker, founder and chief executive officer, said, “We are excited to execute on this key part of our 2013 strategic plan. Establishing our presence in Europe allows us to support our...